Arcturus Therapeutics (ARCT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Arcturus Therapeutics (ARCT) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Arcturus Therapeutics

· ARCT

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

389.396 M

-0.07%

General

Market Cap: $389.4M
Enterprise Value: $220.56M
Shares Outstanding: 28,420,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 83.19%
Operating Margin: -433.36%
Net Profit Margin: -391.90%
FCF Margin: -306.91%
ROA: -41.58%
ROE: -46.54%
ROIC: -52.96%
Current Ratio: 5.88
Debt-to-Equity: 0.13
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.08
P/S: 16.35
P/FCF: —
P/B: 2.26
EV/EBITDA: -2.66

Growth

Rev 1Y: -51.43%
Rev 1Y Fwd Est: -73.43%
Rev 3Y (CAGR): -31.13%
Rev 5Y (CAGR): 47.77%
Rev 10Y (CAGR): 27.04%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $23.8M
Gross Margin: 83.19%
Operating Expenses: $122.95M
Operating Income: -$103.14M
Net Profit: -$93.28M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $191.48M
Working Capital: $163.63M
Total Assets: $224.31M
Net Debt: -$168.55M
Total Liabilities: $52.5M
Total Equity: $171.81M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$72.73M
Cash Flow from Investing: -$41.66K
Cash Flow from Financing: $12.93M
Free Cash Flow: -$73.05M
Capital Expenditures: $318.66K